Technical Analysis for GALT - Galectin Therapeutics Inc.
|Grade||Last Price||% Change||Price Change|
GALT closed up 6.75 percent on Friday, November 16, 2018, on 58 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
|Weak or Absent||Up||Down||Up|
|See historical GALT trend table...|
|Date||Alert Name||Type||% Chg|
|Nov 16||Crossed Above 200 DMA||Bullish||0.00%|
|Nov 16||Wide Bands||Range Expansion||0.00%|
|Nov 15||Crossed Above 20 DMA||Bullish||6.75%|
|Nov 15||Inside Day||Range Contraction||6.75%|
|Nov 15||Wide Bands||Range Expansion||6.75%|
|Nov 14||Fell Below 20 DMA||Bearish||9.52%|
|Nov 14||Wide Bands||Range Expansion||9.52%|
|Nov 13||200 DMA Resistance||Bearish||6.98%|
|Nov 13||180 Bearish Setup||Bearish Swing Setup||6.98%|
|Nov 13||20 DMA Support||Bullish||6.98%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Galectin Therapeutics Inc., a development stage company, engages in the development of therapies for cancer and fibrotic disease. Its lead product candidates include GR-MD-02, a complex polysaccharide polymer for the treatment of liver fibrosis and fatty liver disease for which the company intends to initiate a Phase I clinical trial in patients with non-alcoholic steatohepatitis; and GM-CT-01, a linear polysaccharide polymer comprising mannose and galactose that is in a Phase I/II clinical trial in Europe as a combination therapy with a tumor vaccine in patients with advanced melanoma. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more GALT news...
|52 Week High||9.49|
|52 Week Low||1.28|
|200-Day Moving Average||4.9867|
|50-Day Moving Average||5.2034|
|20-Day Moving Average||4.669|
|10-Day Moving Average||4.892|
|Average True Range||0.4745|
|Chandelier Exit (Long, 3 ATRs )||4.7365|
|Chandelier Exit (Short, 3 ATRs )||5.2735|
|Upper Bollinger Band||5.4003|
|Lower Bollinger Band||3.9377|
|Percent B (%b)||0.77|
|MACD Signal Line||-0.1039|
|Market Cap||177.35 Million|
|Num Shares||35.1 Million|
|Price-to-Earnings (P/E) Ratio||-8.30|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||5.69|
|Resistance 3 (R3)||5.64||5.38||5.59|
|Resistance 2 (R2)||5.38||5.22||5.41||5.55|
|Resistance 1 (R1)||5.22||5.12||5.30||5.27||5.51|
|Support 1 (S1)||4.80||4.80||4.88||4.85||4.61|
|Support 2 (S2)||4.54||4.70||4.57||4.57|
|Support 3 (S3)||4.38||4.54||4.54|
|Support 4 (S4)||4.43|